33 results on '"Mittelman, M."'
Search Results
2. P029 - Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?
3. P004 - Topic: AS01-Diagnosis/AS01a-Cytomorphology: NON-INVASIVE WEB-BASED DIAGNOSTIC ALGORITHM FOR MDS – MODEL PERFORMANCE AND VALIDATION
4. P003 - Topic: AS01-Diagnosis/AS01a-Cytomorphology: ARTIFICIAL INTELLIGENCE MAY HELP THE HEMATOPATHOLOGIST IN EVALUATION OF BONE MASS AND CELLULARITY IN BONE MARROW SPECIMENS OF PATIENTS WITH MDS
5. P51 - Topic: AS08-Treatment/AS08b-Current treatment options -Lenalidomide: LENALIDOMIDE TREATMENT IS ASSOCIATED WITH LOWER SERUM LIPIDS
6. P42 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: LYMPHOID AGGREAGTES IN MDS BONE MARROW BIOPSIES – A PROGNOSTIC MARKER?
7. P35 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES HAVE LOWER BONE MASS
8. P14 - Topic: AS03-Health Economics & Outcome Research/AS03b-Patient-reported outcomes: QUALITY OF LIFE IS IMPAIRED IN ANEMIC MDS PATIENTS, ESPECIALLY WHEN HB DROPS BELOW 9
9. O08 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY
10. Miscommunicating NOTA Can Be Costly to Living Donors
11. P099a The myelodysplastic syndromes (MDS): Is bone marrow examination always necessary?
12. 280 - Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry
13. 247 - Does Bone Marrow Cellularity (BMC) Have a Role in Predicting Prognosis and Survival in Myelodysplastic Syndromes (MDS)?
14. 126 - Diagnosis of Myelodysplastic Syndromes without a Bone Marrow Biopsy: A Non-Invasive Diagnostic Model
15. 83 - The Oral Iron Chelator Deferiprone Decreases Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS)
16. 37 - Eltrombopag in Combination with Azacitidine for First-Line Treatment of MDS Patients with Thrombocytopenia: The Randomized, Placebo-controlled, Phase III, Support Study
17. 22 - Health-Related Quality of Life is Substantially Impaired in Lower-Risk MDS when Compared with Reference Populations and Significantly Affects Overall Survival
18. 19 - Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry
19. 311 MYELODYSPLASTIC SYNDROMES (MDS), THEN AND NOW: A COMPARISON OF TWO PATIENT COHORTS, 30 YEARS APART
20. 284 PATIENTS WITH LR-MDS SUFFER FROM IMMUNE DYSFUNCTION WHICH IS PARTIALLY CORRECTED IN EPO-TREATED PATIENTS
21. 117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)
22. 105 HIGH RESPONSE RATE FOR AZACITIDINE-LENALIDOMIDE (VI-LEN) COMBINATION IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - VILEN-01 PROTOCOL UPDATE
23. 51 PROGNOSTIC IMPACT OF TRANSFUSION INTENSITY ON SURVIVAL AND THROMBOCYTOPENIA IN NEWLY DIAGNOSED LOWER-RISK MDS PATIENTS PARTICIPATING IN THE EUROPEAN LEUKEMIANET MDS (EUMDS) REGISTRY
24. P-287 Infectious events are much more prevalent following a seven compared to five days cycle of azacitidine regardless of patient's age
25. P-098 p53 protein expression predicts outcome and cytogenetic response in patients with low-/INT-1-risk myelodysplastic syndromes treated with lenalidomide
26. 204 Erythropoietin-associated improved immune functions in MDS; dendritic cells as mediators
27. P138 Myelodysplastic syndromes patients treated with recombinant erythropoietin show improved immunological functions
28. PMH22 PREDICTORS OF HEALTH RELATED QUALITY OF LIFE AMONG DEMENTIA CAREGIVERS: A LONGITUDINAL EXAMINATION
29. P195 Stroke in the relatively young (
30. P11 Anemia as a risk factor for ischemic heart disease
31. Fatal aspiration pneumonia caused by an esophageal foreign body
32. The use of immunophenotyping for prediction of early conversion to acute leukemia in myelodysplastic syndromes
33. Osteomyelitis of the clavicle as complication of infected subclavian vein catheter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.